Iylon Precision Oncology shared on LinkedIn:
“New Insights into the Immune System Bring Hope for Liver Cancer
Liver cancer is difficult to treat because every tumor is different, and the disease develops in unique ways in each person. Chronic liver conditions, such as fatty liver disease (MASH), along with changes in cancer cells and the body’s immune system, all play a role in how liver cancer grows and responds to treatment.
Researchers are discovering that certain immune cells in the liver can either fight cancer or unintentionally help it grow. By understanding these immune changes, scientists are identifying new ways to develop Precision immunotherapies that target the specific biology of each patient’s cancer.
These advances could lead to more personalized treatments that improve outcomes, slow disease progression, and offer new hope for people with advanced liver cancer.
The following video outlines the recent advances of Precision Oncology in Liver Cancer.”
You can also read: ‘ctDNA in Gastrointestinal Cancers: What the Evidence Shows‘
